Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1019 | 1109 | 1051 | 962 | 1258 | 1599 |
Fund Return | 1.87% | 10.92% | 5.12% | -1.28% | 4.7% | 4.8% |
Place in category | 228 | 245 | 564 | 326 | 268 | 99 |
% in Category | 27 | 27 | 75 | 63 | 69 | 53 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Schroder GlblDemographicOppC USD | 5.69B | 6.27 | 7.54 | 11.31 | ||
Schroder Emrgng Asia IZ AccUSD | 4.89B | -13.11 | 11.42 | - | ||
SIAsian Opportunities A1 USD Acc | 5.65B | -1.09 | -11.44 | 4.30 | ||
SIAsian Opportunities B USD Acc | 5.65B | -1.11 | -11.53 | 4.19 | ||
SIAsian Opportunities C Inc | 5.65B | -0.88 | -10.28 | 5.67 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Coms Class AE EUR Accumulation Shar | 1.96B | 4.87 | -0.01 | 11.41 | ||
Coms Class IE EUR Accumulation Shar | 1.96B | 5.09 | 0.85 | 12.37 | ||
GS Glbl SCap CoreEqPrtflio Base Inc | 973.47M | 7.75 | 5.11 | 7.35 | ||
GS Glbl SCap CoreEqPrtflioP SnapAcc | 973.47M | 7.80 | 5.39 | 7.65 | ||
GS Glbl SCap CoreEqPrtflioBaseClose | 973.47M | 8.15 | 5.04 | 7.23 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
ICU Medical | US44930G1076 | 2.02 | 101.77 | +1.05% | |
Stericycle | US8589121081 | 1.93 | 47.32 | -0.13% | |
Kemper | US4884011002 | 1.76 | 60.35 | -0.21% | |
Lumentum Holdings Inc | US55024U1097 | 1.58 | 41.40 | -6.14% | |
Liveramp | US53815P1084 | 1.55 | 33.22 | +1.31% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review